| Literature DB >> 34837432 |
Dianalee McKnight1, Lora Bean2, Izabela Karbassi3, Katelynn Beattie4, Thierry Bienvenu5, Hope Bonin6, Ping Fang7, John Chrisodoulou8,9, Michael Friez10, Maria Helgeson1, Rahul Krishnaraj9,11, Linyan Meng7, Lindsey Mighion4, Jeffrey Neul12, Alan Percy13, Simon Ramsden6, Huda Zoghbi7, Soma Das14.
Abstract
The genes MECP2, CDKL5, FOXG1, UBE3A, SLC9A6, and TCF4 present unique challenges for current ACMG/AMP variant interpretation guidelines. To address those challenges, the Rett and Angelman-like Disorders Variant Curation Expert Panel (Rett/AS VCEP) drafted gene-specific modifications. A pilot study was conducted to test the clarity and accuracy of using the customized variant interpretation criteria. Multiple curators obtained the same interpretation for 78 out of the 87 variants (~90%), indicating appropriate usage of the modified guidelines the majority of times by all the curators. The classification of 13 variants changed using these criteria specifications compared to when the variants were originally curated and as present in ClinVar. Many of these changes were due to internal data shared from laboratory members however some changes were because of changes in strength of criteria. There were no two-step classification changes and only 1 clinically relevant change (Likely pathogenic to VUS). The Rett/AS VCEP hopes that these gene-specific variant curation rules and the assertions provided help clinicians, clinical laboratories, and others interpret variants in these genes but also other fully penetrant, early-onset genes associated with rare disorders.Entities:
Keywords: Angelman syndrome; Christianson syndrome; Pitt-Hopkins syndrome; Rett syndrome; guidelines; variant interpretation
Mesh:
Year: 2021 PMID: 34837432 PMCID: PMC9135956 DOI: 10.1002/humu.24302
Source DB: PubMed Journal: Hum Mutat ISSN: 1059-7794 Impact factor: 4.700